Interleukin-20 targets renal cells and is associated with chronic kidney disease

Biochemical and Biophysical Research Communications

Volumn 374, Issue 3, 2008, Pages 448-453

  Wei, Chi Chen ^a,b   Li, Hsing Hui ^a   Hsu, Yu Hsiang ^a   Hsing, Chung Hsi ^c   Sung, Junne Ming ^d   Chang, Ming Shi ^a,c  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHUNG HWA UNIVERSITY OF MEDICAL TECHNOLOGY   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Chronic kidney disease; Cytokines; Fibroblasts; Renal epithelial cells

Indexed keywords

CASPASE 3; INTERLEUKIN 20; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; EPITHELIUM CELL; FIBROBLAST; HEART; IMMUNOCOMPETENT CELL; KIDNEY CELL; KIDNEY TUBULE CELL; LIVER; LUNG PARENCHYMA; MALE; MESANGIUM CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; APOPTOSIS; CELLS, CULTURED; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FIBROBLASTS; HUMANS; INTERLEUKINS; KIDNEY DISEASES; KIDNEY TUBULES; LIVER; LUNG; MALE; MICE; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; TRANSFORMING GROWTH FACTOR BETA1;

RATTUS;

EID: 48849099770     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.07.039     Document Type: Article

References (18)

1. Pestka S., Krause C.D., Sarkar D., Walter M.R., Shi Y., and Fisher P.B. Interleukin-10 and related cytokines and receptors. Annu. Rev. Immunol. 22 (2004) 929-979
2. Wei C.C., Hsu Y.H., Li H.H., Wang Y.C., Hsieh M.Y., Chen W.Y., Hsing C.H., and Chang M.S. IL-20: biological functions and clinical implications. J. Biomed. Sci. 13 (2006) 601-612
3. Tritsaris K., Myren M., Ditlev S.B., Hubschmann M.V., van der Blom I., Hansen A.J., Olsen U.B., Cao R., Zhang J., Jia T., Wahlberg E., Dissing S., and Cao Y. IL-20 is an arteriogenic cytokine that remodels collateral networks and improves functions of ischemic hind limbs. Proc. Natl. Acad. Sci. USA 104 (2007) 15364-15369
4. Hsing C.H., Ho C.L., Chang L.Y., Lee Y.L., Chuang S.S., and Chang M.S. Tissue microarray analysis of interleukin-20 expression. Cytokine 35 (2006) 44-52
5. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Am. J. Kidney Dis. 39 (2002) S1-S266.
6. Schoolwerth A.C., Engelgau M.M., Hostetter T.H., Rufo K.H., Chianchiano D., McClellan W.M., Warnock D.G., and Vinicor F. Chronic kidney disease: a public health problem that needs a public health action plan. Prev. Chronic Dis. 3 (2006) A57
7. Meguid El Nahas A., and Bello A.K. Chronic kidney disease: the global challenge. Lancet 365 (2005) 331-340
8. Stahl P.J., and Felsen D. Transforming growth factor-β, basement membrane, and epithelial-mesenchymal transdifferentiation: implications for fibrosis in kidney disease. Am. J. Pathol. 159 (2001) 1187-1192
9. Mu W., Ouyang X., Agarwal A., Zhang L., Long D.A., Cruz P.E., Roncal C.A., Glushakova O.Y., Chiodo V.A., Atkinson M.A., Hauswirth W.W., Flotte T.R., Rodriguez-Iturbe B., and Johnson R.J. IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease. J. Am. Soc. Nephrol. 16 (2005) 3651-3660
10. Blumberg H., Conklin D., Xu W.F., Grossmann A., Brender T., Carollo S., Eagan M., Foster D., Haldeman B.A., Hammond A., Haugen H., Jelinek L., Kelly J.D., Madden K., Maurer M.F., Parrish-Novak J., Prunkard D., Sexson S., Sprecher C., Waggie K., West J., Whitmore T.E., Yao L., Kuechle M.K., Dale B.A., and Chandrasekher Y.A. Interleukin 20: discovery, receptor identification, and role in epidermal function. Cell 104 (2001) 9-19
11. Chen W.Y., Cheng B.C., Jiang M.J., Hsieh M.Y., and Chang M.S. IL-20 is expressed in atherosclerosis plaques and promotes atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 2090-2095
12. Hsu Y.H., Li H.H., Hsieh M.Y., Liu M.F., Huang K.Y., Chin L.S., Chen P.C., Cheng H.H., and Chang M.S. Function of interleukin-20 as a proinflammatory molecule in rheumatoid and experimental arthritis. Arthritis Rheum. 54 (2006) 2722-2733
13. Wei C.C., Chen W.Y., Wang Y.C., Chen P.J., Lee J.Y., Wong T.W., Chen W.C., Wu J.C., Chen G.Y., Chang M.S., and Lin Y.C. Detection of IL-20 and its receptors on psoriatic skin. Clin. Immunol. 117 (2005) 65-72
14. Ernest S., and Bello-Reuss E. Expression and function of P-glycoprotein in a mouse kidney cell line. Am. J. Physiol. 269 (1995) C323-C333
15. Morrison A.B., and Howard R.M. The functional capacity of hypertrophied nephrons. Effect of partial nephrectomy on the clearance of inulin and PAH in the rat. J. Exp. Med. 123 (1966) 829-844
16. Liu Y. Renal fibrosis: new insights into the pathogenesis and therapeutics. Kidney Int. 69 (2006) 213-217
17. Levin A. Clinical epidemiology of cardiovascular disease in chronic kidney disease prior to dialysis. Semin. Dial. 16 (2003) 101-105
18. Yamamoto T., Noble N.A., Miller D.E., and Border W.A. Sustained expression of TGF-β1 underlies development of progressive kidney fibrosis. Kidney Int. 45 (1994) 916-927